Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Genome-wide DNA methylation and gene expression patterns provide insight into polycystic ovary syndrome development.

Wang XX, Wei JZ, Jiao J, Jiang SY, Yu DH, Li D.

Oncotarget. 2014 Aug 30;5(16):6603-10.

2.

Genome-wide screen of ovary-specific DNA methylation in polycystic ovary syndrome.

Yu YY, Sun CX, Liu YK, Li Y, Wang L, Zhang W.

Fertil Steril. 2015 Jul;104(1):145-53.e6. doi: 10.1016/j.fertnstert.2015.04.005. Epub 2015 May 5.

PMID:
25956362
3.

Hypomethylation of the LH/choriogonadotropin receptor promoter region is a potential mechanism underlying susceptibility to polycystic ovary syndrome.

Wang P, Zhao H, Li T, Zhang W, Wu K, Li M, Bian Y, Liu H, Ning Y, Li G, Chen ZJ.

Endocrinology. 2014 Apr;155(4):1445-52. doi: 10.1210/en.2013-1764. Epub 2014 Feb 14.

PMID:
24527662
4.

Epigenetic and Transcriptional Alterations in Human Adipose Tissue of Polycystic Ovary Syndrome.

Kokosar M, Benrick A, Perfilyev A, Fornes R, Nilsson E, Maliqueo M, Behre CJ, Sazonova A, Ohlsson C, Ling C, Stener-Victorin E.

Sci Rep. 2016 Mar 15;6:22883. doi: 10.1038/srep22883.

5.

Systems Genetics Reveals the Functional Context of PCOS Loci and Identifies Genetic and Molecular Mechanisms of Disease Heterogeneity.

Jones MR, Brower MA, Xu N, Cui J, Mengesha E, Chen YD, Taylor KD, Azziz R, Goodarzi MO.

PLoS Genet. 2015 Aug 25;11(8):e1005455. doi: 10.1371/journal.pgen.1005455. eCollection 2015 Aug.

6.

Quantitative analysis of follistatin (FST) promoter methylation in peripheral blood of patients with polycystic ovary syndrome.

Sang Q, Zhang S, Zou S, Wang H, Feng R, Li Q, Jin L, He L, Xing Q, Wang L.

Reprod Biomed Online. 2013 Feb;26(2):157-63. doi: 10.1016/j.rbmo.2012.10.011. Epub 2012 Oct 23.

PMID:
23265961
7.

Differential gene expression in granulosa cells from polycystic ovary syndrome patients with and without insulin resistance: identification of susceptibility gene sets through network analysis.

Kaur S, Archer KJ, Devi MG, Kriplani A, Strauss JF 3rd, Singh R.

J Clin Endocrinol Metab. 2012 Oct;97(10):E2016-21. doi: 10.1210/jc.2011-3441. Epub 2012 Aug 17.

8.

Epigenetic mechanism underlying the development of polycystic ovary syndrome (PCOS)-like phenotypes in prenatally androgenized rhesus monkeys.

Xu N, Kwon S, Abbott DH, Geller DH, Dumesic DA, Azziz R, Guo X, Goodarzi MO.

PLoS One. 2011;6(11):e27286. doi: 10.1371/journal.pone.0027286. Epub 2011 Nov 4.

9.

Genome-wide methylated DNA immunoprecipitation analysis of patients with polycystic ovary syndrome.

Shen HR, Qiu LH, Zhang ZQ, Qin YY, Cao C, Di W.

PLoS One. 2013 May 21;8(5):e64801. doi: 10.1371/journal.pone.0064801. Print 2013.

10.

Basic research in PCOS: are we reaching new frontiers?

Ben-Shlomo I, Younis JS.

Reprod Biomed Online. 2014 Jun;28(6):669-83. doi: 10.1016/j.rbmo.2014.02.011. Epub 2014 Mar 4. Review.

PMID:
24768413
11.

Comprehensive analysis of genome-wide DNA methylation across human polycystic ovary syndrome ovary granulosa cell.

Xu J, Bao X, Peng Z, Wang L, Du L, Niu W, Sun Y.

Oncotarget. 2016 May 10;7(19):27899-909. doi: 10.18632/oncotarget.8544.

12.

Promoter methylation of yes-associated protein (YAP1) gene in polycystic ovary syndrome.

Jiang LL, Xie JK, Cui JQ, Wei D, Yin BL, Zhang YN, Chen YH, Han X, Wang Q, Zhang CL.

Medicine (Baltimore). 2017 Jan;96(2):e5768. doi: 10.1097/MD.0000000000005768.

13.

A molecular mechanism underlying ovarian dysfunction of polycystic ovary syndrome: hyperandrogenism induces epigenetic alterations in the granulosa cells.

Qu F, Wang FF, Yin R, Ding GL, El-Prince M, Gao Q, Shi BW, Pan HH, Huang YT, Jin M, Leung PC, Sheng JZ, Huang HF.

J Mol Med (Berl). 2012 Aug;90(8):911-23. doi: 10.1007/s00109-012-0881-4. Epub 2012 Feb 21.

PMID:
22349439
14.

The relationship between insulin resistance and CpG island methylation of LMNA gene in polycystic ovary syndrome.

Ting W, Yanyan Q, Jian H, Keqin H, Duan M.

Cell Biochem Biophys. 2013;67(3):1041-7. doi: 10.1007/s12013-013-9602-z.

PMID:
23605101
15.

Pathway Analysis Based on a Genome-Wide Association Study of Polycystic Ovary Syndrome.

Shim U, Kim HN, Lee H, Oh JY, Sung YA, Kim HL.

PLoS One. 2015 Aug 26;10(8):e0136609. doi: 10.1371/journal.pone.0136609. eCollection 2015.

16.

The molecular phenotype of polycystic ovary syndrome (PCOS) theca cells and new candidate PCOS genes defined by microarray analysis.

Wood JR, Nelson VL, Ho C, Jansen E, Wang CY, Urbanek M, McAllister JM, Mosselman S, Strauss JF 3rd.

J Biol Chem. 2003 Jul 18;278(29):26380-90. Epub 2003 May 6.

17.

A subpathway-based method of drug reposition for polycystic ovary syndrome.

Liu HY, Liu JQ, Mai ZX, Zeng YT.

Reprod Sci. 2015 Apr;22(4):423-30. doi: 10.1177/1933719114542025. Epub 2014 Jul 11.

18.

Functional microarray analysis of differentially expressed genes in granulosa cells from women with polycystic ovary syndrome related to MAPK/ERK signaling.

Lan CW, Chen MJ, Tai KY, Yu DC, Yang YC, Jan PS, Yang YS, Chen HF, Ho HN.

Sci Rep. 2015 Oct 13;5:14994. doi: 10.1038/srep14994.

19.

Characterization of microRNA profile in human cumulus granulosa cells: Identification of microRNAs that regulate Notch signaling and are associated with PCOS.

Xu B, Zhang YW, Tong XH, Liu YS.

Mol Cell Endocrinol. 2015 Mar 15;404:26-36. doi: 10.1016/j.mce.2015.01.030. Epub 2015 Jan 23.

PMID:
25622783
20.

Genetic and gene expression analyses of the polycystic ovary syndrome candidate gene fibrillin-3 and other fibrillin family members in human ovaries.

Prodoehl MJ, Hatzirodos N, Irving-Rodgers HF, Zhao ZZ, Painter JN, Hickey TE, Gibson MA, Rainey WE, Carr BR, Mason HD, Norman RJ, Montgomery GW, Rodgers RJ.

Mol Hum Reprod. 2009 Dec;15(12):829-41. doi: 10.1093/molehr/gap072. Epub 2009 Aug 19.

Supplemental Content

Support Center